Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials

Neuraxial and Neurolytic Analgesia for Intractable Pain

The recruitment status of this study is unknown because the information has not been verified recently.
Verified June 2008 by University of Wisconsin, Madison.
Recruitment status was  Recruiting
Information provided by:
University of Wisconsin, Madison Identifier:
First received: September 9, 2005
Last updated: June 12, 2008
Last verified: June 2008

The purpose of this study is to collect longitudinal data on outcomes of neuraxial or neurolytic procedures in patients with intractable cancer and chronic noncancer pain so that we may contribute to the growing evidence for or against these therapies and to provide data for ongoing quality improvement activities.


Study Type: Observational
Study Design: Observational Model: Case-Only
Time Perspective: Prospective
Official Title: Neuraxial and Neurolytic Analgesia for Intractable Pain

Further study details as provided by University of Wisconsin, Madison:

Estimated Enrollment: 100
Study Start Date: January 2005
Estimated Study Completion Date: January 2010

Ages Eligible for Study:   18 Years and older
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   No
Sampling Method:   Non-Probability Sample
Study Population

This is a prospective case series analysis. Subjects over the age of 18 who are offered neuraxial (epidural or intrathecal) analgesia or neurolytic procedures (e.g. celiac, hypogastric, or sacral nerve plexus block) to treat intractable pain through the UW Interventional Pain Program.


Inclusion Criteria:

  • treated for intractable pain by the UW Interventional Pain Treatment program
  • inpatient or outpatient

Exclusion Criteria:

  • less than 18 years of age
  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its identifier: NCT00167726

Contact: Andrea Maser 608-265-6544

United States, Wisconsin
University of Wisconsin Recruiting
Madison, Wisconsin, United States, 53792
Contact: Andrea Maser    608-265-6544      
Sponsors and Collaborators
University of Wisconsin, Madison
Principal Investigator: Nalini Sehgal, MD University of Wisconsin, Madison
  More Information

No publications provided

Responsible Party: Nalini Sehgal MD, University of Wisconsin School of Medicine and Public Health Identifier: NCT00167726     History of Changes
Other Study ID Numbers: 2004-0482
Study First Received: September 9, 2005
Last Updated: June 12, 2008
Health Authority: United States: Institutional Review Board

Additional relevant MeSH terms:
Pain, Intractable
Nervous System Diseases
Neurologic Manifestations
Signs and Symptoms processed this record on November 19, 2014